Services
Disease Landscape
Hub & Patient Journey

See how patients truly move through care.
The clinical landscape is identified using drug, medical device, and procedure databases alongside scientific data. Real-world patient activity is combined with centre and clinician analysis to define a validated universe of proven expertise. Within this landscape, patient movement is mapped to reveal referral patterns and the clinical relationships between clinicians and institutions that shape diagnosis and treatment decisions.

Clinicians who influence patient pathways in daily practice are identified, rather than only those most visible in scientific publications. Profiling combines scientific leadership with real-world clinical activity to capture the full spectrum of decision-makers, including established experts, high-volume treaters, emerging specialists, and clinicians benefiting from targeted disease education. Multiple signals are analysed, ranging from treatment expertise to disease correlations, misdiagnosis patterns, professional influence, and industry collaboration.
Each centre is analysed individually to determine its true role within the patient pathway and treatment landscape. Analysis goes beyond registry classifications and includes diagnostic activity, referral patterns, and treatment involvement to understand how and where care is delivered. Disease correlations and misdiagnosis patterns also help identify centres that may encounter patients through related conditions. This approach reveals practices, hospitals, and testing locations that play a meaningful role in patient care but may remain invisible in conventional registries or datasets.
Historical and ongoing clinical trials, principal investigator activity, and sponsor involvement are assessed to determine where research capability and therapeutic expertise are concentrated. This highlights centres with proven experience in clinical development, early adoption, and implementation of new therapies.
Analysis of clinician interactions within professional networks reveals the broader circle of influence surrounding recognised leaders. This ensures engagement strategies reach the clinicians who diagnose, refer, and treat patients in practice, supporting more effective awareness, education, and therapy adoption initiatives.
Patient movement through the healthcare system is mapped to reflect how care is delivered in practice, rather than how it appears in traditional datasets. Referral behaviour between local hospitals and specialised centres is analysed to identify where conditions are first suspected, where diagnosis is confirmed, and where treatment ultimately takes place. Network analysis also uncovers the professional relationships that shape patient referrals. Clinicians who may appear less prominent in traditional datasets often act as consistent referral sources or close collaborators of key opinion leaders and decision-makers. Revealing these connections provides a more accurate picture of clinical influence and highlights engagement opportunities frequently overlooked.
A clear and comprehensive understanding of referral dynamics, diagnostic touchpoints, and the clinicians who truly influence patient journeys.